We are analyzing https://link.springer.com/article/10.1007/s00125-016-3940-5.

Title:
Hepatic glucose and lipid metabolism | Diabetologia
Description:
The liver has a central role in the regulation of systemic glucose and lipid fluxes during feeding and fasting and also relies on these substrates for its own energy needs. These parallel requirements are met by coordinated control of carbohydrate and lipid fluxes into and out of the Krebs cycle, which is highly tuned to nutrient availability and heavily regulated by insulin and glucagon. During progression of type 2 diabetes, hepatic carbohydrate and lipid biosynthesis fluxes become elevated, thus contributing to hyperglycaemia and hypertriacylglycerolaemia. Over this interval there are also significant fluctuations in hepatic energy state. To date, it is not known to what extent abnormal glucose and lipid fluxes are causally linked to altered energy states. Recent evidence that the glucose-lowering effects of metformin appear to be mediated by attenuation of hepatic energy generation places an additional spotlight on the interdependence of hepatic biosynthetic and oxidative fluxes. The transition from fasting to feeding results in a significant re-direction of hepatic glucose and lipid fluxes and may also incur a temporary hepatic energy deficit. At present, it is not known to what extent these variables are additionally modified by type 2 diabetes and/or non-alcoholic fatty liver disease. Thus, there is a compelling need to measure fluxes through oxidative, gluconeogenic and lipogenic pathways and determine their relationship with hepatic energy state in both fasting and fed conditions. New magnetic resonance-based technologies allow these variables to be non-invasively studied in animal models and humans. This review summarises a presentation given at the symposium entitled ‘The liver in focus’ at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Kenneth Cusi, DOI: 10.1007/s00125-016-3952-1 , and by Hannele Yki-Järvinen, DOI: 10.1007/s00125-016-3944-1 ) and a commentary by the Session Chair, Michael Roden (DOI: 10.1007/s00125-016-3911-x ).
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

hepatic, pubmed, google, scholar, cas, cycle, article, glucose, fluxes, energy, krebs, lipid, fatty, liver, metabolism, central, acid, conditions, metab, fasting, diabetes, state, gluconeogenesis, mitochondrial, oxidative, synthesis, physiol, type, endocrinol, jones, feeding, carbohydrate, insulin, disease, oxidation, nafld, rates, acetylcoa, lipogenesis, substrates, humans, nmr, plasma, nonalcoholic, metabolic, production, flux, information, generation, anaplerotic,

Topics {✒️}

magnetic resonance-based technologies vivo 13c-isotopomer high-fructose weight-maintaining diet gas chromatography-mass spectrometry de novo lipogenesis short-chain fatty acids gut-brain neural circuits branched-chain amino acids mild mitochondrial uncoupling 14c-labeled propionate metabolism mitochondrially generated acetyl-coa hyperinsulinaemic–hyperglycaemic clamp conditions fatty acid β-oxidation delgado tc cytosolic malonyl-coa levels including simple sugars krebs cycle metabolism stz-diabetes rat model krebs cycle flux adipose tissue lipolysis tca cycle flux hepatic krebs cycle fatty acid metabolism de-convoluting oxidative diet-induced nafld reflects hepatic lipogenesis promoting acetyl-coa generation article jones review summarises sunny ne citric acid cycle privacy choices/manage cookies krebs cycle fluxes krebs cycle driving 13c nmr study positional 13c-enrichment profiles perry rj hepatic energy metabolism attenuate pyruvate carboxylase 13c-enriched precursors hepatic intermediary metabolism 13c nmr measurements fatty liver disease [u-13c]propionate fatty acid synthesis lipogenic enzyme controlled mitochondrial energy generation [u-13c]glucose hepatic insulin resistance

Questions {❓}

A key question is: how are the changes in hepatic energy state related to those of hepatic glucose and lipid metabolic fluxes?
Given that, under fed conditions, glycolytic substrates appear to contribute at most ∼50% of the acetyl-CoA requirements for oxidation and that NEFA oxidation is efficiently repressed by malonyl-CoA, are there alternative substrates that could contribute to mitochondrial energy generation?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hepatic glucose and lipid metabolism
         description:The liver has a central role in the regulation of systemic glucose and lipid fluxes during feeding and fasting and also relies on these substrates for its own energy needs. These parallel requirements are met by coordinated control of carbohydrate and lipid fluxes into and out of the Krebs cycle, which is highly tuned to nutrient availability and heavily regulated by insulin and glucagon. During progression of type 2 diabetes, hepatic carbohydrate and lipid biosynthesis fluxes become elevated, thus contributing to hyperglycaemia and hypertriacylglycerolaemia. Over this interval there are also significant fluctuations in hepatic energy state. To date, it is not known to what extent abnormal glucose and lipid fluxes are causally linked to altered energy states. Recent evidence that the glucose-lowering effects of metformin appear to be mediated by attenuation of hepatic energy generation places an additional spotlight on the interdependence of hepatic biosynthetic and oxidative fluxes. The transition from fasting to feeding results in a significant re-direction of hepatic glucose and lipid fluxes and may also incur a temporary hepatic energy deficit. At present, it is not known to what extent these variables are additionally modified by type 2 diabetes and/or non-alcoholic fatty liver disease. Thus, there is a compelling need to measure fluxes through oxidative, gluconeogenic and lipogenic pathways and determine their relationship with hepatic energy state in both fasting and fed conditions. New magnetic resonance-based technologies allow these variables to be non-invasively studied in animal models and humans. This review summarises a presentation given at the symposium entitled ‘The liver in focus’ at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Kenneth Cusi, DOI: 10.1007/s00125-016-3952-1 , and by Hannele Yki-Järvinen, DOI: 10.1007/s00125-016-3944-1 ) and a commentary by the Session Chair, Michael Roden (DOI: 10.1007/s00125-016-3911-x ).
         datePublished:2016-04-05T00:00:00Z
         dateModified:2016-04-05T00:00:00Z
         pageStart:1098
         pageEnd:1103
         sameAs:https://doi.org/10.1007/s00125-016-3940-5
         keywords:
            Anaplerosis
            De novo lipogenesis
            Deuterated water
             13C Isotopomer analysis
            Krebs cycle
            Magnetic resonance spectroscopy
            Pyruvate cycling
            Review
            Internal Medicine
            Metabolic Diseases
            Human Physiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-016-3940-5/MediaObjects/125_2016_3940_Fig1_HTML.gif
         isPartOf:
            name:Diabetologia
            issn:
               1432-0428
               0012-186X
            volumeNumber:59
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:John G. Jones
               affiliation:
                     name:UC Biotech
                     address:
                        name:Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Cantanhede, Portugal
                        type:PostalAddress
                     type:Organization
                     name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC)
                     address:
                        name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hepatic glucose and lipid metabolism
      description:The liver has a central role in the regulation of systemic glucose and lipid fluxes during feeding and fasting and also relies on these substrates for its own energy needs. These parallel requirements are met by coordinated control of carbohydrate and lipid fluxes into and out of the Krebs cycle, which is highly tuned to nutrient availability and heavily regulated by insulin and glucagon. During progression of type 2 diabetes, hepatic carbohydrate and lipid biosynthesis fluxes become elevated, thus contributing to hyperglycaemia and hypertriacylglycerolaemia. Over this interval there are also significant fluctuations in hepatic energy state. To date, it is not known to what extent abnormal glucose and lipid fluxes are causally linked to altered energy states. Recent evidence that the glucose-lowering effects of metformin appear to be mediated by attenuation of hepatic energy generation places an additional spotlight on the interdependence of hepatic biosynthetic and oxidative fluxes. The transition from fasting to feeding results in a significant re-direction of hepatic glucose and lipid fluxes and may also incur a temporary hepatic energy deficit. At present, it is not known to what extent these variables are additionally modified by type 2 diabetes and/or non-alcoholic fatty liver disease. Thus, there is a compelling need to measure fluxes through oxidative, gluconeogenic and lipogenic pathways and determine their relationship with hepatic energy state in both fasting and fed conditions. New magnetic resonance-based technologies allow these variables to be non-invasively studied in animal models and humans. This review summarises a presentation given at the symposium entitled ‘The liver in focus’ at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Kenneth Cusi, DOI: 10.1007/s00125-016-3952-1 , and by Hannele Yki-Järvinen, DOI: 10.1007/s00125-016-3944-1 ) and a commentary by the Session Chair, Michael Roden (DOI: 10.1007/s00125-016-3911-x ).
      datePublished:2016-04-05T00:00:00Z
      dateModified:2016-04-05T00:00:00Z
      pageStart:1098
      pageEnd:1103
      sameAs:https://doi.org/10.1007/s00125-016-3940-5
      keywords:
         Anaplerosis
         De novo lipogenesis
         Deuterated water
          13C Isotopomer analysis
         Krebs cycle
         Magnetic resonance spectroscopy
         Pyruvate cycling
         Review
         Internal Medicine
         Metabolic Diseases
         Human Physiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-016-3940-5/MediaObjects/125_2016_3940_Fig1_HTML.gif
      isPartOf:
         name:Diabetologia
         issn:
            1432-0428
            0012-186X
         volumeNumber:59
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:John G. Jones
            affiliation:
                  name:UC Biotech
                  address:
                     name:Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Cantanhede, Portugal
                     type:PostalAddress
                  type:Organization
                  name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC)
                  address:
                     name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Diabetologia
      issn:
         1432-0428
         0012-186X
      volumeNumber:59
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:UC Biotech
      address:
         name:Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Cantanhede, Portugal
         type:PostalAddress
      name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC)
      address:
         name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:John G. Jones
      affiliation:
            name:UC Biotech
            address:
               name:Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Cantanhede, Portugal
               type:PostalAddress
            type:Organization
            name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC)
            address:
               name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Cantanhede, Portugal
      name:APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal

External Links {🔗}(168)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.18s.

LINK . SPRINGER . COM {}